Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor Jun 15, 2020 9:30am EDT
PAVmed Subsidiary Lucid Diagnostics Receives Preliminary Payment Determination for EsoGuard™ Esophageal DNA Test Jun 11, 2020 9:30am EDT
PAVmed Reports Preliminary First Quarter 2020 Financial Results and Provides Business Update May 21, 2020 4:00pm EDT
PAVmed Receives FDA 510(k) Clearance for its CarpX™ Minimally Invasive Carpal Tunnel Device Apr 21, 2020 9:30am EDT
PAVmed Reports Preliminary Fourth Quarter 2019 Financial Results and Provides Business Update Apr 09, 2020 4:44pm EDT
PAVmed Subsidiary Lucid Diagnostics’ EsoCheck Esophageal Cell Collection Device Receives Prestigious Edison Best New Product Award Apr 02, 2020 9:30am EDT
PAVmed Receives $6.3 Million in Gross Proceeds from Completion of November 2019 Financing Mar 31, 2020 9:30am EDT
